Cash on Hand for Revolution Medicines (RVMD)
According to Revolution Medicines's latest reported financial statements, the company's latest reported cash and short-term investments is $1.91B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingCash on HandSwitch metric
Latest period
$1.91B
YoY change
-11.5%
5Y CAGR
+35.7%
Peak year (2024)
$2.29B
Latest annual
$2.03B
Cash on Hand history chart for Revolution Medicines (RVMD) from 2017 to 2025
Cash on Hand history table for Revolution Medicines (RVMD) from 2017 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | $2.03B | -11.5% | -$263.62M | ||
| 2024 | $2.29B | +23.5% | +$436.34M | ||
| 2023 | $1.85B | +187.3% | +$1.21B | ||
| 2022 | $644.94M | +11.8% | +$67.89M | ||
| 2021 | $577.05M | +30.9% | +$136.31M | ||
| 2020 | $440.74M | +259.0% | +$317.98M | ||
| 2019 | $122.76M | +76.4% | +$53.17M | ||
| 2018 | $69.59M | +666.5% | +$60.51M | ||
| 2017 | $9.08M | — | — |
Cash on Hand values are taken from Revolution Medicines's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual cash and short-term investments for Revolution Medicines (RVMD) came in at $2.03B – declined 11.5% year-over-year.
Through 2020–2025 (5 years), Revolution Medicines cash and short-term investments delivered a +35.7% annualised rate; with the latest reading among the more recent periods of the dataset.
Revolution Medicines cash and short-term investments declined from $2.29B in 2024 to $2.03B in 2025, a 11.5% drawdown.
Across the available history, cash and short-term investments reached its high of $2.29B in 2024 and its low of $9.08M in 2017.
Among 8 Healthcare peers, Revolution Medicines (RVMD) ranks 9th; the peer median for cash and short-term investments is $11.85B.
Revolution Medicines Cash on Hand by Year
Revolution Medicines Cash on Hand 2025: $2.03B
Revolution Medicines cash and short-term investments in 2025 was $2.03B, declined 11.5% below 2024.
Revolution Medicines Cash on Hand 2024: $2.29B
Revolution Medicines cash and short-term investments in 2024 was $2.29B, grew 23.5% from 2023. This figure represents the highest annual value in the available history.
Revolution Medicines Cash on Hand 2023: $1.85B
Revolution Medicines cash and short-term investments in 2023 was $1.85B, surged 187.3% from 2022.
Revolution Medicines Cash on Hand 2022: $644.94M
Revolution Medicines cash and short-term investments in 2022 was $644.94M, grew 11.8% from 2021.
Revolution Medicines Cash on Hand 2021: $577.05M
Revolution Medicines cash and short-term investments in 2021 was $577.05M.
See more financial history for Revolution Medicines (RVMD).
Sector peers — Cash on Hand
Companies in the same sector as Revolution Medicines, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group (UNH) | $28.12B | Healthcare |
| Novo Nordisk (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co. (MRK) | $14.56B | Healthcare |
| Amgen (AMGN) | $9.13B | Healthcare |
| Eli Lilly (LLY) | $7.27B | Healthcare |
| AstraZeneca (AZN) | $5.74B | Healthcare |
| AbbVie (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Revolution Medicines's cash and short-term investments?
Latest reported cash and short-term investments for Revolution Medicines (RVMD) is $1.91B (period ending March 31, 2026).
How has Revolution Medicines cash and short-term investments changed year-over-year?
Revolution Medicines (RVMD) cash and short-term investments changed -11.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Revolution Medicines cash and short-term investments?
Revolution Medicines (RVMD) cash and short-term investments compound annual growth rate is +35.7% over the most recent 5 years available.
When did Revolution Medicines cash and short-term investments hit its highest annual value?
Revolution Medicines cash and short-term investments reached its highest annual value of $2.29B in 2024.
What was Revolution Medicines cash and short-term investments in 2024?
Revolution Medicines (RVMD) cash and short-term investments in 2024 was $2.29B.
What was Revolution Medicines cash and short-term investments in 2025?
Revolution Medicines (RVMD) cash and short-term investments in 2025 was $2.03B.
RVMD Key Financials
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
RVMD Overview
Company profile, financial tools, and key metrics
RVMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RVMD How It Makes Money
Discover visual breakdown — where revenue comes from and where it goes.
RVMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RVMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RVMD Daily Price Character
Explosive · 50.7% historical win rate (green days). Streaks & record days.
RVMD Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.